Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
RMC-9805
i
Other names:
RMC-9805, KRASG12D inhibitor, KRAS G12D inhibitor, RMC9805, RMC 9805
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Revolution Medicines
Drug class:
KRAS G12D inhibitor
Related drugs:
‹
MRTX1133 (8)
KS-58 (3)
QTX3034 (1)
QTX3046 (1)
YL-17231 (1)
HRS-4642 (0)
Undisclosed MSC-derived Exosomes with KrasG12D siRNA (0)
MRTX1133 (8)
KS-58 (3)
QTX3034 (1)
QTX3046 (1)
YL-17231 (1)
HRS-4642 (0)
Undisclosed MSC-derived Exosomes with KrasG12D siRNA (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
KRAS G12D
Non Small Cell Lung Cancer
KRAS G12D
Non Small Cell Lung Cancer
RMC-9805
Sensitive: C2 – Inclusion Criteria
RMC-9805
Sensitive
:
C2
RMC-9805
Sensitive: C2 – Inclusion Criteria
RMC-9805
Sensitive
:
C2
KRAS G12D
Pancreatic Ductal Adenocarcinoma
KRAS G12D
Pancreatic Ductal Adenocarcinoma
RMC-9805
Sensitive: D – Preclinical
RMC-9805
Sensitive
:
D
RMC-9805
Sensitive: D – Preclinical
RMC-9805
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login